Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $1.35 USD
Change Today +0.0193 / 1.45%
Volume 39.3K
SKBI On Other Exchanges
As of 8:10 PM 11/25/15 All times are local (Market data is delayed by at least 15 minutes).

skystar bio-pharmaceutical (SKBI) Snapshot

Previous Close
Day High
Day Low
52 Week High
12/12/14 - $4.83
52 Week Low
10/2/15 - $0.85
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield

Related News

No related news articles were found.

skystar bio-pharmaceutical (SKBI) Related Businessweek News

No Related Businessweek News Found

skystar bio-pharmaceutical (SKBI) Details

Skystar Bio-Pharmaceutical Company researches, develops, produces, markets, and sells veterinary healthcare and medical care products in the People’s Republic of China. The company offers micro-organism products, veterinary medicines for poultry and livestock, feed additives, and bio-pharmaceutical veterinary vaccines. It markets its products through distributers and franchise distributors, as well as directly to customers. The company is headquartered in Xi’an, the People’s Republic of China.

skystar bio-pharmaceutical (SKBI) Top Compensated Officers

Chairman and Chief Executive Officer
Total Annual Compensation: $121.6K
Chief Financial Officer
Total Annual Compensation: $182.5K
Compensation as of Fiscal Year 2013.

skystar bio-pharmaceutical (SKBI) Key Developments

Skystar Bio Pharmaceutical Company Receives Non-Compliance Notice From NASDAQ

Skystar Bio Pharmaceutical Company announced that on November 17, 2015, it received a letter from NASDAQ Stock Market indicating that that Skystar failed to comply with Nasdaq's filing requirement set forth in Listing Rule 5250(c)(1) because it failed to file its Form 10-Q for the fiscal quarter ended September 30, 2015. The Company previously disclosed a notification from Nasdaq informing the Company that is was subject to delisting because it failed to comply with Nasdaq's filing requirements set forth in Listing Rule 5250(c)(1) because it failed to file its Form 10-K for the fiscal year ended December 31, 2014, and Forms 10-Q for the periods ended March 31, and June 30, 2015. The failure to file the Quarterly Report constitutes an additional basis for delisting. The Company also previously disclosed that Nasdaq had notified the Company of two additional, and separate, bases for delisting under Listing Rule 5250(b)(1) (failure to disclose material non-public information) and Listing Rule 5101 (public interest concerns). The Company has a hearing scheduled for December 3, 2015 for the hearing panel to review the delisting determination.

Skystar Bio Pharmaceutical Company announced delayed 10-Q filing

On 11/16/2015, Skystar Bio Pharmaceutical Company announced that they will be unable to file their next 10-Q by the deadline required by the SEC.

Skystar Bio-Pharmaceutical Company Receives Notice From Nasdaq

Skystar Bio-Pharmaceutical Company announced that on November 4, 2015 it received a letter from the Nasdaq Hearings Panel that granted the request of Skystar Bio-Pharmaceutical Company to extend the automatic 15-day stay of suspension from The Nasdaq Stock Market, until the hearing on the merits scheduled for December 3, 2015, and a determination regarding the company's listing status.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SKBI:US $1.35 USD +0.0193

SKBI Competitors

Market data is delayed at least 15 minutes.

Company Last Change
China Animal Husbandry Industry Co Ltd CNY17.18 CNY 0.00
Guangdong VTR Bio-Tech Co Ltd CNY61.88 CNY +1.89
Inner Mongolia Jinyu Group Co Ltd CNY33.49 CNY -0.01
Xinjiang Tecon Animal Husbandry Bio-Technology Co Ltd CNY10.66 CNY -0.07
View Industry Companies

Industry Analysis


Industry Average

Valuation SKBI Industry Range
Price/Earnings 1.0x
Price/Sales 0.2x
Price/Book 0.1x
Price/Cash Flow 1.1x
TEV/Sales NM Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact SKYSTAR BIO-PHARMACEUTICAL, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at